Lee's Pharmaceutical Holdings Limited (FRA:L1PA)

Market Cap	73.81M -28.6%
Revenue (ttm)	157.13M +2.6%
Net Income	10.06M -1.2%
EPS	0.02 -1.3%
Shares Out	n/a
PE Ratio	7.34
Forward PE	n/a
Dividend	0.01 (4.46%)
Ex-Dividend Date	Sep 12, 2025

Volume	n/a
Average Volume	1
Open	0.1170
Previous Close	0.1160
Day's Range	0.1160 - 0.1170
52-Week Range	0.1160 - 0.2700
Beta	n/a
RSI	40.98
Earnings Date	Mar 30, 2026

About FRA:L1PA

Lee's Pharmaceutical Holdings Limited, an investment holding company, develops, manufactures, markets, and sells pharmaceutical products in the People's Republic of China, Hong Kong, and internationally. It focuses on various disease areas, such as cardiovascular, woman’s health, pediatrics, rare diseases, oncology, dermatology, and obstetrics. It operates in Proprietary and Generic Products; and Licensed-In Products segments. The Proprietary and Generic Products segment manufactures and sells Nadroparin Calcium injection and Livaracine to trea...

• Industry: Pharmaceutical Preparations
• Founded: 1994
• Employees: 1,036
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: L1PA

Financial Performance

In 2025, FRA:L1PA's revenue was 1.44 billion, an increase of 2.57% compared to the previous year's 1.40 billion. Earnings were 91.94 million, a decrease of -1.25%.

Financial numbers in HKD